Effects of vecuronium and rocuronium in antagonistic laryngeal muscles and the anterior tibial muscle in the cat

Acta Anaesthesiologica Scandinavica

Volumn 44, Issue 5, 2000, Pages 503-510

  Michalek Sauberer, Andrea ^a   Gilly, H ^b   Steinbereithner, K ^b   Vizi, E S ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Animal model: cat; Larynx: posterior cricoarytenoid muscle, lateral cricoarytenoid muscle, vocal cords; Neuromuscular blocking agents: vecuronium, rocuronium

Indexed keywords

ROCURONIUM; VECURONIUM;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; DRUG EFFICACY; GLOTTIS; LARYNX MUSCLE; MUSCLE FUNCTION; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL; TIBIALIS ANTERIOR MUSCLE; VOCAL CORD;

ANDROSTANOLS; ANIMALS; CATS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; HINDLIMB; LARYNGEAL MUSCLES; MUSCLE, SKELETAL; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PERONEAL NERVE; RECURRENT LARYNGEAL NERVE; TIME FACTORS; VECURONIUM BROMIDE; VOCAL CORDS;

EID: 0034094691     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2000.00502.x     Document Type: Article

References (35)

1. 1. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology 1991: 74: 833-837.
2. 2. Moorthy SS, Reddy RV, Dunfield JA, Radpour S, Dierdorf SF. The effect of muscle relaxants on cricothyroid muscle: a report of three cases. Anesth Analg 1996: 82: 657-660.
3. 3. Iwasaki H, Igarashi M, Omote K, Namiki A. Vecuronium neuromuscular blockade at the cricothyroid and posterior cricoarytenoid muscles of the larynx and at the adductor pollicis muscle in humans. J Clin Anesth 1994: 6: 14-17.
4. 4. Pavlin EG, Holle RH, Schoene RB. Recovery of airway protection compared with ventilation in humans after paralysis with curare. Anesthesiology 1989: 70: 381-385.
5. 5. Kopman AF. Surrogate endpoints and neuromuscular recovery. (Editorial) Anesthesiology 1997: 87: 1029-1031.
6. 6. Gilly H, Redl G, Streinzer W, Zrunek M, Draxler V. Zur Pharmakodynamik von Vecuronium an Stimmband-und Thenarmuskulatur. Anaesthesist 1986: 35: 661-664.
7. 7. Donati F, Plaud B, Meistelman C. A method to measure elicited contraction of laryngeal adductor muscles during anesthesia. Anesthesiology 1991: 74: 827-832.
8. 8. Sauberer A. Entwicklung und Prüfung eines Modells zur simultanen Bewertung der Muskelrelaxation an drei intrinsischen Larynxmuskeln und dem M. tibialis anterior. Wien Klin Wochenschr 1993: 105: 208-211.
9. 9. Viby-Mogensen J, Engbaek J, Eriksson LI, Gramstad L, Jensen E, Jensen FS et al. Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996: 40: 59-74.
10. 10. Meretoja OA, Theroux M. Can final EMG baseline be used as a reference to calculate neuromuscular recovery? Acta Anaesthesiol Scand 1997: 41: 492-496.
11. 11. Meistelman C, Plaud B, Donati F. Neuromuscular effects of succinylcholine on the vocal cords and adductor pollicis muscles. Anesth Analg 1991: 73: 278-282.
12. 12. Wright PM, Caldwell JE, Miller RD. Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans. Anesthesiology 1994: 81: 1110-1115.
13. 13. Meistelman C, Plaud B, Donati F. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth 1992: 39: 665-669.
14. 14. Ungureanu D, Meistelman C, Frossard J, Donati F. The orbicularis oculi and the adductor pollicis muscles as monitors of atracurium block of laryngeal muscles. Anesth Analg 1993: 77: 775-779.
15. 15. Plaud B, Debaene B, Lequeau F, Meistelman C, Donati F. Mivacurium neuromuscular block at the adductor muscles of the larynx and adductor pollicis in humans. Anesthesiology 1996: 85: 77-81.
16. 16. Debaene B, Lieutaud T, Billard V, Meistelman C. ORG 9487 neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans. Anesthesiology 1997: 86: 1300-1305.
17. 17. Ibebunjo C, Hall LW. Succinylcholine and vecuronium blockade of the diaphragm, laryngeal and limb muscles in the anaesthetized goat. Can J Anaesth 1994: 41: 36-42.
18. 18. Engbaek J, Skovgaard LT, Friis B, Kann T, Viby-Mogensen J. Monitoring of the neuromuscular transmission by electromyography (I). Stability and temperature dependence of evoked EMG response compared to mechanical twitch recordings in the cat. Acta Anaesthesiol Scand 1992: 36: 495-504.
19. 19. Engbaek J, Skovgaard LT, Friis B, Kann T, Viby-Mogensen J. Monitoring of the neuromuscular transmission by electromyography (II). Evoked compound EMG area, amplitude and duration compared to mechanical twitch recording during onset and recovery of pancuronium-induced blockade in the cat. Acta Anaesthesiol Scand 1993: 37: 788-798.
20. 20. Lam HS, Morgan DL, Lampard DG. Derivation of reliable electromyograms and their relation to tension in mammalian skeletal muscles during synchronous stimulation. Electroencephalogr Clin Neurophysiol 1979: 46: 72-80.
21. 21. Kopman AF, Mallhi MU, Neuman GG, Justo MD. Re-establishment of paralysis using mivacurium following apparent full recovery from mivacurium-induced neuromuscular block. Anaesthesia 1996: 51: 41-44.
22. 22. Paton WD, Waud DR. The margin of safety of neuromuscular transmission. J Physiol 1967: 191: 59-90.
23. 23. Campkin NT, Hood JR, Fauvel NJ, Feldman SA. The effect of residual receptor occupancy on sensitivity to repeated vecuronium. Anaesthesia 1993: 48: 572-574.
24. 24. Feldman SA, Hood JR, Campkin NT, Rehm S. Sensitivity to second dose of mivacurium. Anaesthesia 1994: 49: 671-674.
25. 25. Van den Brom RH, Houwertjes MC, Agoston S. A method for studying the pharmacodynamic profile of neuromuscular blocking agents on vocal cord movements in anaesthetized cats. Br J Pharmacol 1991: 102: 861-864.
26. 26. Iwasaki H, Igarashi M, Namiki A, Omote K. Differential neuromuscular effects of vecuronium on the adductor and abductor laryngeal muscles and tibialis anterior muscle in dogs. Br J Anaesth 1994: 72: 321-323.
27. 27. Kotby MN, Haugen LK. Attempts at evaluation of the function of various laryngeal muscles in the light of muscle and nerve stimulation experiments in man. Acta Otolaryngol 1970: 70: 419-427.
28. 28. Muir AW, Houston J, Green KL, Marshall RJ, Bowman WC, Marshall IG. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 1989: 63: 400-410.
29. 29. Rex MA. A review of the structural and functional basis of laryngospasm and a discussion of the nerve pathways involved in the reflex and its clinical significance in man and animals. Br J Anaesth 1970: 42: 891-899.
30. 30. Teig E, Dahl HA, Thorkelsen H. Actomyosin ATPase activity of human laryngeal muscles. Acta Otolaryngol 1978: 85: 272-281.
31. 31. Sahgal V, Hast MH. Histochemistry of primate laryngeal muscles. Acta Otolaryngol 1974: 78: 277-281.
32. 32. Rossi G, Cortesina G. Morphological study of the laryngeal muscles in man. Acta Otolaryngol 1965: 59: 575-592.
33. 33. Ibebunjo C, Hall LW. Muscle fibre diameter and sensitivity to neuromuscular blocking drugs. Br J Anaesth 1993: 71: 732-733.
34. 34. Ibebunjo C, Srikant CB, Donati F. Duration of succinylcholine and vecuronium blockade but not potency correlates with the ratio of endplate size to fibre size in seven muscles in the goat. Can J Anaesth 1996: 43: 485-494.
35. 35. Igarashi M, Iwasaki H. Mechanism of the differential sensitivity in the rat adductor and abductor laryngeal muscles to a non-depolarizing neuromuscular blocker. Br J Anaesth 1995: 75: 339-343.